AmpliPhi, SPH to combat antibiotic-resistant super bugs
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2012
Singapore: Australia-based AmpliPhi Biosciences is looking to acquire Brookvale, a Sydney-based Special Phage Services (...Read more
Embryonic stem cells remain a sticky wicket
Australia | Analysis | By Piyusha Chatterjee | 3 Comment | 31 Jan, 2013
Dr Shinya Yamanaka and Sir John Gurdon's discovery of induced pluripotent stem cells (iPS) has given the world an altern...Read more
Nutraceutical cure for migraine
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jan, 2013
Singapore: Researchers at Griffith Health Institute's Genomics Research Center have entered the final phase in an extens...Read more
Aus Medtech association: Reimbursements remain constrained
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2013
The Medical Technology Association of Australia (MTAA) is the national association of Australia representing companies i...Read more
STA to commercialize leukemia drug in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
Singapore: US-based Ariad Pharmaceuticals has granted Specialised Therapeutics Australia (STA), a specialty pharmaceutic...Read more
Australia reviews pharma patenting
Australia | News | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2012
Singapore: The federal government in Australia has initiated a review of the patenting of pharmaceuticals in the country...Read more
Takeda initiates Ph3 trial for Ixazomib in Asia
Australia | News | By BioSpectrum Bureau | 0 Comment | 28 Jan, 2014
Singapore: Takeda Development Center Shanghai (TDC Shanghai) and Takeda Development Center Asia has commenced TOURMALINE...Read more
CSL progresses on Novartis influenza vaccine biz acquisition
Australia | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015
Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...Read more
Aussie's IDT to manufacture 23 generic drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Apr, 2015
Singapore: US FDA has accepted the transfer of ownership of 23 generic drug products to Australia based IDT. Formalising...Read more
Catalant acquires Australia's packaging giant Pharmapak
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Apr, 2015
Singapore: US-based Catalant Pharma Solutions announced the acquisition of Pharmapak Technologies, an Australian pharmac...Read more
Australia grants support for TB research
Australia | News | By BioSpectrum Bureau | 0 Comment | 27 Mar, 2015
Singapore: In a bid to eradicate the menace of TB, The Australian Department of Foreign Affairs and Trade (DFAT) has ann...Read more
Bionomics initiaties trial of anxiety drug in France
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Feb, 2015
Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...Read more
Hatchtech gets $6 mn for head lice R&D
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2012
Singapore: Specialty pharmaceutical company Hatchtech has completed a $6 million financing led by OneVentures Innovatio...Read more
Australian sandalwood maker buys two US pharma firms
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2015
Singapore: West Australian sandalwood producer TFS Corporation has announced the acquisition of two US pharma firms in a...Read more
Saluda Medical secures $5 mn from NSW Govt
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: NICTA start-up company Saluda Medical has been awarded $5 million by the New South Wales Government to suppor...Read more
Invion completes patient enrolment for asthma drug trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2015
Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...Read more
CPR ventures into large molecule analytics
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2013
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...Read more
BioDiem, US NIAID advance TB research
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has detailed a new phase of res...Read more